C-Path Reaffirms Commitment to Advancing Regulatory Science for Disease-Modifying Therapies in Type 1 Diabetes

Posted on Mon/15/JuneMon/15/June by Roxan Olivas

Regulatory milestone underscores opportunity for shared regulatory-science and evidence frameworks to support the next generation of therapies.Continue reading→

AZBio Member Spotlight – Aces Diagnostics

Posted on Mon/15/JuneMon/15/June by Ava Woods

Aces Diagnostics is focused on solving one of the biggest gaps in infectious disease diagnostics: the lack of accurate testing for Lyme disease.Continue reading→

C-Path Appoints Biotech Executive and Investor Dr. Milad Alucozai to Board of Directors

Posted on Thu/11/JuneMon/15/June by Roxan Olivas

TUCSON, Ariz., June 11, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Milad Alucozai, DrPH, MPH, M.Sc., to its Board of Directors.Continue reading→

C-Path Appoints Biotechnology Leader and Veteran Life-Science Attorney Yalonda Howze to Board of Directors

Posted on Wed/10/JuneWed/10/June by Roxan Olivas

TUCSON, Ariz., June 10, 2026 — Critical Path Institute® (C-Path) today announced the appointment of Yalonda Howze, J.D., to its Board of Directors. Howze brings nearly two decades of executive leadership and legal experience across the biotechnology and life-science sectors, including her most recent current service as interim chief executive officer and president of Generation Bio.Continue reading→

Critical Path Institute to Convene Drug Development Leaders at 2026 Global Impact Conference

Posted on Tue/9/JuneTue/9/June by Roxan Olivas

Annual conference returns to Washington, D.C., Sept. 15-16; addresses challenges in establishing a new paradigm for how evidence of efficacy and safety is generated.Continue reading→

AZBio Member Spotlight – Prickly Pear Health

Posted on Mon/8/JuneMon/8/June by Ava Woods

Based in Arizona, Prickly Pear Health is building technology to uncover one of the most overlooked gaps in healthcare: the connection between women’s hormonal health and brain health.Continue reading→

Picard Medical / SynCardia Advances Emperor Total Artificial Heart Program with Successful Next-Generation Preclinical Implant Studies

Posted on Tue/2/JuneTue/2/June by AZBio

— Independent dual motor ventricular design demonstrates stable full circulatory support across all study procedures —

— Advancing second-generation Emperor TAH development toward a fully implantable system —
Continue reading→

AZBio Member Spotlight – Navi Nurses

Posted on Mon/1/JuneMon/1/June by Ava Woods

Based in Arizona, Navi Nurses is redefining what personalized nursing care looks like outside of the hospital, ensuring that no patient or family has to navigate complex medical situations alone.Continue reading→

NIH SBIR and STTR Parent Notices of Funding Opportunity (NOFOs) have officially been released

Posted on Fri/29/MayFri/29/May by AZBio

These programs provide non-dilutive funding to help small businesses advance innovative technologies and bring promising discoveries closer to commercialization. Whether you’re developing a new therapeutic, diagnostic, medical device, digital health solution, or research tool, NIH funding can help accelerate your path forward.Continue reading→